Evidence map›Paper›PMID 38677284›Full record

ArticleCell reports methods2024

Systematic analysis of proteome turnover in an organoid model of pancreatic cancer by dSILO.

Alison B Ross, Darvesh Gorhe, Jenny Kim Kim, Stefanie Hodapp, Lela DeVine, Karina M Chan, Iok In Christine Chio, Marko Jovanovic, Marina Ayres Pereira

Open access · goldAbstract read
In one paragraph

Article in Cell reports methods, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Alison B RossDepartment of Biological Sciences, Columbia University, New York City, NY 10027, USA.
Darvesh GorheDepartment of Biological Sciences, Columbia University, New York City, NY 10027, USA.
Jenny Kim KimDepartment of Biological Sciences, Columbia University, New York City, NY 10027, USA.
Stefanie HodappDepartment of Biological Sciences, Columbia University, New York City, NY 10027, USA.
Lela DeVineDepartment of Biology, Barnard College, New York, NY 10027, USA; Institute for Cancer Genetics, Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA.
Karina M ChanInstitute for Cancer Genetics, Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA.
Iok In Christine ChioInstitute for Cancer Genetics, Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address: ic2445@cumc.columbia.edu.
Marko JovanovicDepartment of Biological Sciences, Columbia University, New York City, NY 10027, USA. Electronic address: mj2794@columbia.edu.
Marina Ayres PereiraInstitute for Cancer Genetics, Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address: marinaayrespereira@gmail.com.
Columbia University · USColumbia University Irving Medical Center · USBarnard College · US

Funding

Studying the role of eIF4A in Pancreatic CancerR01CA267870 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Christine Iok In Chio · 2022 to 2026
$2.3M
Characterizing the role of MSRA in pancreatic tumorigenesisR01CA273023 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Christine Iok In Chio · 2023 to 2026
$1.8M
NCI NIH HHS R01 CA267870NCI NIH HHS R01 CA273023
6 · The paper itself

Abstract

The role of protein turnover in pancreatic ductal adenocarcinoma (PDA) metastasis has not been previously investigated. We introduce dynamic stable-isotope labeling of organoids (dSILO): a dynamic SILAC derivative that combines a pulse of isotopically labeled amino acids with isobaric tandem mass-tag (TMT) labeling to measure proteome-wide protein turnover rates in organoids. We applied it to a PDA model and discovered that metastatic organoids exhibit an accelerated global proteome turnover compared to primary tumor organoids. Globally, most turnover changes are not reflected at the level of protein abundance. Interestingly, the group of proteins that show the highest turnover increase in metastatic PDA compared to tumor is involved in mitochondrial respiration. This indicates that metastatic PDA may adopt alternative respiratory chain functionality that is controlled by the rate at which proteins are turned over. Collectively, our analysis of proteome turnover in PDA organoids offers insights into the mechanisms underlying PDA metastasis.

Indexed as

Carcinoma, Pancreatic DuctalOrganoidsPancreatic NeoplasmsProteomeHumansIsotope LabelingProteomicsProteomeCP: BiotechnologyCP: Cancer biologydSILOmetastasesPDAprotein half-lifeprotein turnoverrespirasomeSILAC

Identifiers

PMID38677284
PMCPMC11133751
OpenAlexW4395678222

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.